Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-05

Clinical Trial Update: Botulinum Toxin for Erectile Dysfunction [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for botulinum toxin in erectile dysfunction showing completed phase 2/3 study results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Cairo University | Conditions: Sexual Dysfunction, Erectile Dysfunction | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-12-05